Pravin is the Managing Partner and Head of Litigation at Anand and Anand. Awarded the INTA 2021 President’s Award, AIPPI Award of Merit and recognised as the “Most Innovative Lawyer” for the Asia Pacific Region by the Financial Times, Mr Anand has experience of appearing in more than 2,500 cases in over 42 years of his practice as an IP lawyer. Some of the landmarks in his career include patent lawsuits that transformed the pharmaceutical and bio-technology enforcement regime in India, including Merck v. Glenmark; Roche v. Cipla; the Monsanto case; and a large number of other suits on behalf of Pfizer, BMS, AstraZeneca, etc. He also has to his credit India’s first anti-anti-suit injunction order (InterDigital v. Xiaomi); a software patent law suit conferring protection (Ferid Allani case); the development of damages culture in a large number of cases that recognised not only punitive, but compensatory, exemplary and aggravated damages (Philips v. AmazeStore); India’s first post-trial SEP judgment (Philips v. Bhagirathi); development of unique remedies such as the “Tree Planting Order” (Merck case); and an order benefitting adolescent girls (Hermes case).
This third edition provides answers and insight into how luxury businesses can protect their brands in a range of jurisdictions. Written by experts, topics include the protection of intellectual property using trademark, copyright or design; privacy; product placement; and the protection of corporat...
Luxury Law is a comprehensive guide providing answers and insight into how luxury businesses can protect their brands in a range of jurisdictions. Written by experts, topics include the protection of intellectual property using trademark, copyright or design, privacy, product placement and the prote...